Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines

被引:29
作者
Ma, L
Broomfield, S
Lavery, C
Lin, SL
Xiao, W
Bacchetti, S
机构
[1] McMaster Univ, Dept Pathol, Canc Res Grp, Hamilton, ON L8N 3Z5, Canada
[2] Univ Saskatchewan, Dept Microbiol, Saskatoon, SK S7N 5E5, Canada
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA
基金
英国医学研究理事会;
关键词
CIR1; CROC1; UEV-1; immortalization; tumorigenesis differential display;
D O I
10.1038/sj.onc.1202058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acquisition of the immortal phenotype by tumor cells represents an essential and potentially rate-limiting step in tumorigenesis, To identify changes in gene expression that are associated with the early stages of cell immortalization, we compared genetically matched pairs of pre-immortal and immortal human cell clones by mRNA differential display. Two transcripts, denoted CIR1 and CIR2, were identified which were up-regulated in immortal cells. Sequence analysis revealed CIR1 to be identical to the recently cloned CROC1/UEV-1 gene, whereas CIR2 corresponds to an as yet uncharacterized 1.2 kb mRNA, A 5-6-fold elevation in CIR1/CROC1 expression and a 2-3-fold elevation in CIR2 expression were observed in SV40-transformed human enbryonic kidney cells immediately following proliferative crisis, suggesting a potential role for these genes in immortalization, Expression of CIR1/CROC1 was found to be elevated also in a variety of immortal human tumor-derived cell lines, as compared to their normal tissue counterparts. These results are compatible with induction of CIR1/CROC1 being an early event in the acquisition of immortality and with a role for this gene in the immortal phenotype of tumor cells.
引用
收藏
页码:1321 / 1326
页数:6
相关论文
共 35 条
  • [1] Avilion AA, 1996, CANCER RES, V56, P645
  • [2] Bacchetti S, 1996, CANCER SURV, V28, P197
  • [3] The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines
    Brinkmann, U
    Gallo, M
    Polymeropoulos, MH
    Pastan, I
    [J]. GENOME RESEARCH, 1996, 6 (03) : 187 - 194
  • [4] BROOMFIELD S, 1998, IN PRESS P NATL ACAD
  • [5] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929
  • [6] EDWARDS PAW, 1993, CANCER SURV, V16, P79
  • [7] SV 40-INDUCED TRANSFORMATION OF HUMAN DIPLOID CELLS - CRISIS AND RECOVERY
    GIRARDI, AJ
    JENSEN, FC
    KOPROWSKI, H
    [J]. JOURNAL OF CELLULAR AND COMPARATIVE PHYSIOLOGY, 1965, 65 (01): : 69 - +
  • [8] REPLICATIVE SENESCENCE - THE HUMAN FIBROBLAST COMES OF AGE
    GOLDSTEIN, S
    [J]. SCIENCE, 1990, 249 (4973) : 1129 - 1133
  • [9] Harley CB, 1997, CANCER SURV, V29, P263
  • [10] ONCOGENES AND CELL-DEATH
    HARRINGTON, EA
    FANIDI, A
    EVAN, GI
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) : 120 - 129